Nucleus pulposus fibrosis in intervertebral disc degeneration: Mechanisms, mediators, and therapeutic strategies

Intervertebral disc degeneration (IVDD) is a leading cause of low back pain (LBP) worldwide, yet no current therapy can prevent or reverse its progression. Nucleus pulposus (NP) fibrosis has emerged as a critical pathological feature of IVDD. This review systematically summarizes the current understanding of the mechanisms underlying NP fibrosis and explores advances in targeted therapeutic strategies. During IVDD, the NP undergoes profound extracellular matrix (ECM) remodeling characterized by progressive loss of aggrecan and type II collagen (COL II), accompanied by pathological accumulation of type I collagen (COL I), fibronectin, and small leucine-rich proteoglycans (SLRPs). This matrix transformation is driven by activated matrix-degrading enzymes, including matrix metalloproteinases (MMPs) and a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTSs), and by the phenotypic transition of resident NP cells toward fibroblast-like and myofibroblast states. Single-cell transcriptomic studies have revealed increasing cellular heterogeneity during degeneration, with expansion of fibrotic subpopulations and identification of novel markers such as fibroblast activation protein α (FAPα), fibroblast-specific protein 1 (FSP1), and α-smooth muscle actin (α-SMA). The fibrotic cascade is orchestrated by multiple signaling pathways, including transforming growth factor β (TGF-β)/small mothers against decapentaplegic (SMAD), Ras homolog family member A (RhoA)/myocardin-related transcription factor A (MRTF-A), and Yes-associated protein (YAP)/transcriptional coactivator with PDZ-binding motif (TAZ)-TEA domain transcription factor (TEAD), which are activated by mechanical stress, inflammatory mediators, and intercellular crosstalk among disc cells, immune cells, and endothelial cells. Notably, specific profibrotic macrophage subsets play a central role through the secreted phosphoprotein 1 (SPP1)‑cluster of differentiation 44 (CD44) axis and other communication networks. Preclinical strategies targeting profibrotic pathways have shown promise, yet the challenge remains to suppress chronic pathological fibrosis without ablating beneficial reparative responses. Future directions include standardizing fibrotic cell nomenclature, elucidating the transition from adaptive to maladaptive fibrosis, and developing stage-specific interventions guided by precise biomarkers. Achieving this balance represents the central opportunity for advancing intervertebral disc (IVD) regeneration and repair.

Authors

Institutions

Publication Details

Journal
Spine Research
Published
2026-11-16
DOI
https://doi.org/10.1097/br9.0000000000000053
Primary Topic
Spine and Intervertebral Disc Pathology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Nucleus pulposus fibrosis in intervertebral disc degeneration: Mechanisms, mediators, and therapeutic strategies

卢益中, Taotao Xu, Chengliang Wu, Hongfeng Ruan et al.
6 links
Spine Research
Spine and Intervertebral Disc Pathology
article

Nucleus pulposus fibrosis in intervertebral disc degeneration: Mechanisms, mediators, and therapeutic strategies

卢益中, Taotao Xu, Chengliang Wu, Hongfeng Ruan, Lei Chen, Weiqiang Zhao, Wenqing Ma, Shuchao Shen
article en

Abstract

Intervertebral disc degeneration (IVDD) is a leading cause of low back pain (LBP) worldwide, yet no current therapy can prevent or reverse its progression. Nucleus pulposus (NP) fibrosis has emerged as a critical pathological feature of IVDD. This review systematically summarizes the current understanding of the mechanisms underlying NP fibrosis and explores advances in targeted therapeutic strategies. During IVDD, the NP undergoes profound extracellular matrix (ECM) remodeling characterized by progressive loss of aggrecan and type II collagen (COL II), accompanied by pathological accumulation of type I collagen (COL I), fibronectin, and small leucine-rich proteoglycans (SLRPs). This matrix transformation is driven by activated matrix-degrading enzymes, including matrix metalloproteinases (MMPs) and a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTSs), and by the phenotypic transition of resident NP cells toward fibroblast-like and myofibroblast states. Single-cell transcriptomic studies have revealed increasing cellular heterogeneity during degeneration, with expansion of fibrotic subpopulations and identification of novel markers such as fibroblast activation protein α (FAPα), fibroblast-specific protein 1 (FSP1), and α-smooth muscle actin (α-SMA). The fibrotic cascade is orchestrated by multiple signaling pathways, including transforming growth factor β (TGF-β)/small mothers against decapentaplegic (SMAD), Ras homolog family member A (RhoA)/myocardin-related transcription factor A (MRTF-A), and Yes-associated protein (YAP)/transcriptional coactivator with PDZ-binding motif (TAZ)-TEA domain transcription factor (TEAD), which are activated by mechanical stress, inflammatory mediators, and intercellular crosstalk among disc cells, immune cells, and endothelial cells. Notably, specific profibrotic macrophage subsets play a central role through the secreted phosphoprotein 1 (SPP1)‑cluster of differentiation 44 (CD44) axis and other communication networks. Preclinical strategies targeting profibrotic pathways have shown promise, yet the challenge remains to suppress chronic pathological fibrosis without ablating beneficial reparative responses. Future directions include standardizing fibrotic cell nomenclature, elucidating the transition from adaptive to maladaptive fibrosis, and developing stage-specific interventions guided by precise biomarkers. Achieving this balance represents the central opportunity for advancing intervertebral disc (IVD) regeneration and repair.

Spine Research
Zhejiang Chinese Medical University (CN), Zhejiang Provincial Hospital of TCM (CN)
Good health and well-being
Spine and Intervertebral Disc Pathology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon